1. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 58

    A consortium approach for consumer-reported outcome measures to assess tobacco- and nicotine-containing products

    ACQUADRO C.(1) on behalf of the CORESTA CROM Task Force: AYALA-FIERRO F.(2); BLACK R.(3); CAHOURS X.(4); CHREA C.(5); CURTIN G.(6); GILES L.(7); McCAFFREY S.(3); PARK C.H.(8); PRASAD K.(9); SHERWOOD N.(10); SHIFFMAN S.(11); SMITH J.(6); SPIES E.(5)
    (1) Mapi Research Trust, Lyon, France; (2) ITG Brands, Greensboro, NC, U.S.A.; (3) Altria Client Services, Richmond, VA, U.S.A.; (4) SEITA - Imperial Brands, Paris, France; (5) Philip Morris Products S.A., Neûchatel, Switzerland; (6) RAIS, Winston-Salem, NC, U.S.A.; (7) JT Int'l SA, Genève, Switzerland; (8) KT&G Research Institute, Daejeon, Republic of Korea; (9) British American Tobacco, Southampton, U.K.; (10) Neil Sherwood Consulting, Commugny, Switzerland; (11) Pinney Associates, Pittsburgh, PA, U.S.A.
    In the tobacco space, consumer-reported outcome measures (CROM) are essential for understanding motivations, subjective effects, and behavior. Such measures have become particularly important with the advent of candidate modified risk tobacco products ...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 32

    Consumers’ responses to communication materials of a novel heat-not-burn tobacco product

    CHREA C.(1); KALLISCHNIGG G.(2); SANDERS E.(3); BEACHER F.(4); MAGNANI P.(4); RAMAZZOTTI A.(4); WEITKUNAT R.(1)
    (1) Philip Morris Products S.A. (part of Philip Morris International group of companies), PMI R&D, Neuchâtel, Switzerland; (2) ARGUS – Statistics and Information Systems in Environment and Public Health GmbH, Berlin, Germany; (3) Edward Sanders Scientific Consulting, Peseux, Switzerland; (4) Philip Morris International Management S.A. (PMI) (part of Philip Morris International group of companies), Lausanne, Switzerland
    Modified risk tobacco products (MRTPs) are defined by the U.S. Food and Drug Administration (FDA) as tobacco products that are sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco ...